Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

VEGF 165 (AA 27-191) Protein

Recombinant protein expressed in HEK-293 Cells.
Catalog No. ABIN7275824

Quick Overview for VEGF 165 (AA 27-191) Protein (ABIN7275824)

Target

VEGF 165

Protein Type

Recombinant

Origin

  • 18
  • 2
  • 1
Human

Source

  • 9
  • 6
  • 2
  • 1
  • 1
  • 1
  • 1
HEK-293 Cells

Purity

> 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
  • Protein Characteristics

    AA 27-191

    Purpose

    Human VEGF165 Protein

    Sequence

    Ala27-Arg191

    Characteristics

    Recombinant Human VEGF165 Protein is expressed from HEK293 without tag.It contains Ala27-Arg191.

    Sterility

    0.22 μm filtered

    Endotoxin Level

    Less than 0.05 EU per μg by the LAL method.

    Biological Activity Comment

    Immobilized Human VEGF165 at 1μg/ml (100μl/well) on the plate. Dose response curve for Human VEGFR2, mFc Tag with the EC50 of 74.2ng/ml determined by ELISA. See testing image for detail.
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.

    Buffer

    Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.

    Storage

    -20 °C,-80 °C

    Storage Comment

    -20 to -80°C for 12 months as supplied from date of receipt., -80°C for 3-6 months after reconstitution., 2-8°C for 2-7 days after reconstitution., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

    Expiry Date

    12 months
  • Target

    VEGF 165

    Alternative Name

    VEGF165

    Background

    Human papillomavirus (HPV) infection is an established risk factor for cervical carcinogenesis. VEGF165 was significantly higher, whereas VEGFC and VEGFD were significantly lower in malignant cervical carcinoma tissues as compared to normal cervix tissues. Expression levels of VEGF121 and VEGFC were significantly associated with type of tumor growth while VEGF165 was significantly associated with lymph node metastasis.

    Molecular Weight

    19.2 kDa. Due to glycosylation, the protein migrates to 20-30 kDa based on Tris-Bis PAGE result.

    UniProt

    P15692-4
You are here:
Chat with us!